Insider Transactions in Q2 2024 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 18
2024
|
Christine Berni Silverstein Director |
SELL
Open market or private sale
|
Direct |
25,821
-29.38%
|
$103,284
$4.51 P/Share
|
Jun 18
2024
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
25,890
-41.22%
|
$103,560
$4.51 P/Share
|
Jun 05
2024
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,951
-5.81%
|
$43,804
$4.52 P/Share
|
Jun 05
2024
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,621
-7.18%
|
$154,484
$4.52 P/Share
|
Jun 05
2024
|
Joseph Walter Vazzano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,408
-7.02%
|
$65,632
$4.52 P/Share
|
Jun 03
2024
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-0.13%
|
$2,812
$4.38 P/Share
|
May 16
2024
|
Leila Alland Director |
BUY
Open market or private purchase
|
Direct |
11,000
+11.72%
|
$44,000
$4.71 P/Share
|
Apr 26
2024
|
Faith L. Charles Director |
BUY
Open market or private purchase
|
Direct |
7,550
+8.79%
|
$22,650
$3.28 P/Share
|
Apr 25
2024
|
Vishwas Seshadri Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.82%
|
$30,000
$3.2 P/Share
|
Apr 25
2024
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,608
+2.34%
|
$16,824
$3.14 P/Share
|
Apr 25
2024
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Open market or private purchase
|
Direct |
8,600
+4.36%
|
$25,800
$3.24 P/Share
|